Lung cancer (LC) is the most common cancer and the leading cause of cancer-related death worldwide. The 5-year survival rate for LC remains low at 18% and is 5% for patients with metastatic disease, while the 5-year overall survival rate of patients with stage I NSCLC can reach 77.9%, hence early diagnosis and treatment of LC is the key to improve the prognosis. As a non-invasive detection technique, Raman spectroscopy can realize the non-destructive detection of the differences in molecular level structure between cancerous tissues and normal tissues, which can be used for the early diagnosis of lung cancer. The aim of this review is to summarize the progress of Raman spectroscopycombined with different tissue or body fluid samplesin the d...
In 2020, approximately 10 million people died of cancer, rendering this disease the second leading c...
Breast cancer is the most common cancer among women worldwide, with an estimated 1.7 million cases a...
In 2020, approximately 10 million people died of cancer, rendering this disease the second leading c...
In recent years, many researches have explored the diagnostic value of Raman spectroscopy in multipl...
Patient survival remains poor even after diagnosis in lung cancer cases, and the molecular events re...
lung cancer patients from 'at risk' controls and 'at risk' control subjects from healthy control sub...
Lung cancer has an 18% five year survival rate, which is among the lowest in all cancer types. Typic...
Despite significant improvements in the way breast cancer is managed and treated, it continues to pe...
The aim of this study was to investigate whether Raman spectroscopy could be used to identify and po...
This study aimed at determining the concentration of P-selectins in lung cancer patients in differen...
Raman spectroscopy mapping was used to study ex vivo fresh lung tissues and compare to histology sec...
10.1117/12.577419Progress in Biomedical Optics and Imaging - Proceedings of SPIE5630 I340-34
Lung cancer is the leading cause of cancer deaths worldwide accounting for 1.69 million deaths in 20...
Novel approaches toward understanding the evolution of disease can lead to the discovery of biomarke...
We previously published a comprehensive review paper reviewing the Raman spectroscopy of biological ...
In 2020, approximately 10 million people died of cancer, rendering this disease the second leading c...
Breast cancer is the most common cancer among women worldwide, with an estimated 1.7 million cases a...
In 2020, approximately 10 million people died of cancer, rendering this disease the second leading c...
In recent years, many researches have explored the diagnostic value of Raman spectroscopy in multipl...
Patient survival remains poor even after diagnosis in lung cancer cases, and the molecular events re...
lung cancer patients from 'at risk' controls and 'at risk' control subjects from healthy control sub...
Lung cancer has an 18% five year survival rate, which is among the lowest in all cancer types. Typic...
Despite significant improvements in the way breast cancer is managed and treated, it continues to pe...
The aim of this study was to investigate whether Raman spectroscopy could be used to identify and po...
This study aimed at determining the concentration of P-selectins in lung cancer patients in differen...
Raman spectroscopy mapping was used to study ex vivo fresh lung tissues and compare to histology sec...
10.1117/12.577419Progress in Biomedical Optics and Imaging - Proceedings of SPIE5630 I340-34
Lung cancer is the leading cause of cancer deaths worldwide accounting for 1.69 million deaths in 20...
Novel approaches toward understanding the evolution of disease can lead to the discovery of biomarke...
We previously published a comprehensive review paper reviewing the Raman spectroscopy of biological ...
In 2020, approximately 10 million people died of cancer, rendering this disease the second leading c...
Breast cancer is the most common cancer among women worldwide, with an estimated 1.7 million cases a...
In 2020, approximately 10 million people died of cancer, rendering this disease the second leading c...